BCR-ABL-IN-11
BCR-ABL-IN-11 (Compound 2) is a BCR-ABL inhibitor. BCR-ABL-IN-11 shows anticancer activity against chronic myelogenous leukemia (CML) (IC50 of 129.61 μM for K562 cells) [1].
Product Specifications
CAS Number
2362-25-6
UNSPSC
12352211
Target
Bcr-Abl
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=C(C1=CC=C(C=C1)N)NC2=CC=CC(NC(C3=CC=C(C=C3)N)=O)=C2
Molecular Formula
C20H18N4O2
Molecular Weight
346.38
References & Citations
[1]Peng H, et al. Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening. Bioorg Med Chem Lett. 2003 Nov 3;13 (21) :3693-9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RK11141 96 Tests
Human Potassium voltage-gated channel subfamily B member 2 (KCNB2) ELISA Kit
Sign In for Pricing
View Details ![Rabbit Monoclonal CCL14/HCC-1/HCC-3 Antibody (007) [DyLight 680]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
NBP2-89519FR 0.1 mL
Rabbit Monoclonal CCL14/HCC-1/HCC-3 Antibody (007) [DyLight 680]
Sign In for Pricing
View Details